Emerging as a promising therapeutic option , Retatrutide is generating significant attention within the medical community. This groundbreaking dual stimulator targeting multiple GIP and GLP-1 pathways demonstrates remarkable efficacy in preclinical trials and recent phase 2 clinical testing. Init